CMV in moderately active colitis: much ado about nothing?
Moss
Alan C
AC
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000821:virology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000821:virology*; D003588:Cytopathogenic Effect, Viral; D015774:Ganciclovir / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000821:virology*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology / Q000821:virology; D012189:Retrospective Studies; D014775:Virus Activation / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir